NORDIC BIOSCIENCE A/S: Financial statements 2014
CVR: 30799968
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
NORDIC BIOSCIENCE A/S (CVR 30799968) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 21,530,126 and a net result of DKK 1,086,648 compared with DKK -6,667,393 the year before. That is an increase of 36.4% compared with the year before. Equity in the 2014 report amounted to DKK 15,171,535. The solvency ratio was 8.8%.
- Gross Profit
- DKK 21,530,126
- Profit/Loss
- DKK 1,086,648
- Equity
- DKK 15,171,535
- Total Assets
- DKK 172,954,204
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 21.5 mio. | 1.1 mio. | 15.2 mio. | - |
| 2013 | - | 15.8 mio. | -6.7 mio. | 14.1 mio. | - |
| 2012 | - | - | - | - | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
NORDIC BIOSCIENCE A/S has published its annual report for 2013. Gross profit came to DKK 15,783,274, and the net result was DKK -6,667,393.
About NORDIC BIOSCIENCE A/S
NORDIC BIOSCIENCE A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Morten Asser Karsdal. The board consists of Bente Juel Christiansen, Claus Henrik Christiansen and Thomas Nielsen. The company is owned by NORDIC BIOSCIENCE HOLDING A/S. The company has 121 employees (2018). In 2025, the company reported revenue of DKK 379,345,000 and a net result of DKK 96,537,000 compared with DKK 78,388,000 the year before. Equity in the 2025 report amounted to DKK 131,205,000.